@JD_path
Account based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
Fellow@UC San Diego Mom #Gardener #Cats_lover
San Diego, CA
Joined May 2020
- Tweets1.1K
- Following984
- Followers1K
- Likes3.4K
Jing Di (邸菁) MD, PhD retweeted
WHAT'S NEW IN COLORECTAL TUMORS (WHO 6TH EDITION 2026)
Traditional serrated adenomas (TSA)
An adenomatous polyp with any amount of TSA component should be classified as TSA. If it has high grade dysplasia, then call it TSA with high grade dysplasia
Pic 2: Polyp with TSA component on the left and tubular adenoma component on the right.
How to call it? = TSA
Dr. Srivastava GIPS pathcast youtube.com/live/mdt3Pr4G1Es… #pathology #PathX
Jing Di (邸菁) MD, PhD retweeted
Final version of this article is now posted!
Granular/oncocytic lung carcinomas: what these are, and how they can cause diagnostic problems.
sciencedirect.com/science/ar…
nitter.cf/natasharekhtman/status…
1/ Just out in @ModernPathology
New study from our group: A distinct variant of aggressive lung carcinoma with peculiar pathologic features.
We called these tumors “SAGA” (solid and granular adenocarcinoma) .. sorting them out was in fact a long and winding saga that led to some unexpected insights. 👇
modernpathology.org/article/…
pubmed.ncbi.nlm.nih.gov/4158…
Jing Di (邸菁) MD, PhD retweeted
Stunning example of the cholangioblastic variant of intrahepatic cholangiocarcinoma. At first glance these look like neuroendocrine tumors and there is chromogranin/synaptophysin expression (patchy) but not INSM1. The kicker is inhibin. PMID: 33999553; PMCID: PMC8516671.
Jing Di (邸菁) MD, PhD retweeted
Dear Colleagues,
We learned last week of an unexpected opening in our GI Pathology Fellowship from July 2026- June 2027. If this piques your interest, kindly send your CV to Ms. Adriana Zanaty at adriana.zanaty@miami.edu
Our case material is incredible - a great opportunity!
Jing Di (邸菁) MD, PhD retweeted
Hello everyone!
Let's discuss the contentious Breast Consult Case of the Week 9 #BCCW9
Last week, I shared with you four images of what seemed like a flat intraductal proliferation with mucin secretion, mucin exrtravasation, and floating cells within the extracellular mucin. Most of you..
Jing Di (邸菁) MD, PhD retweeted
🔬 Join us for another captivating CAPA Online Education session on Pediatric Pathology this Sunday! Explore the molecular and histologic features of DICER-1 Syndrome with Dr. Yamin Ma! Mark your calendar 🗓️ 2/16, 7PM ET. Hosted by Dr. Tengfei Wang @TengfeiWang9652 #PathTwitter
Jing Di (邸菁) MD, PhD retweeted
A 27 year old lady presented with dyspareunia and post coital bleeding was found to have an 8.0 cm vaginal mass. Vaginal biopsy was taken.
What is your opinion?
#GYNpath
#Hemepath
#Pathtwitter
#PathX
Jing Di (邸菁) MD, PhD retweeted
📣Continuing our celebration of the 2025 CAPA GoPath Best Abstract Award winners(3/3)!
🥉 Xiao Zhou from Pennsylvania Hospital @PennPathLabMed
🥉 Jing Wang from NYU Langone Health @nyulangone
🥉 Jing Di from University of Kentucky @UKYpathology
Jing Di (邸菁) MD, PhD retweeted
🔬 Excited to announce Dr. Andrew Bellizzi’s @IHC_guy upcoming CAPA Online Education Session on #Immunohistochemistry! Join us on 1/19, 7 PM ET for an in-depth exploration into IHC for diagnosing and classifying neuroendocrine neoplasms. Don’t miss out! Host: @DrChuanChen #IHC
I am pleased to share our latest research published in J Molecular Diagnostic. This work represents a collaborative effort to refine MRD detection in AML, potentially improving patient outcomes through more precise monitoring. pubmed.ncbi.nlm.nih.gov/3961…
Jing Di (邸菁) MD, PhD retweeted
I just updated my notes on "Soft tissue tumors" for my teaching website, "Kurt's Notes" (kurtsnotes.net/).
🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬🔬
Full notes available here: schaberg.faculty.ucdavis.edu…
🔍 Our latest study in Biomedicines explores unique genetic markers in CMML patients at the University of Kentucky, revealing why personalized treatments are crucial. Excited to advance how we tackle this complex disease! Read more about our findings 🔗 mdpi-res.com/d_attachment/bi…
Jing Di (邸菁) MD, PhD retweeted
🧬 Curious about genomics and variant interpretation? Join Dr. Guang (Geoff) Yang from @PennPathLabMed this Sunday as he breaks down the essentials for non-molecular pathologists in this #CAPA OLE session!
📅 10/13/2024, 7 PM ET
Hosted by Dr. Xiaoming Zhang
Jing Di (邸菁) MD, PhD retweeted
🔍 Uncover the secrets of inherited blood cancer with Dr. Mark David Ewalt from @MSKCancerCenter @MSKPathology. Mark your 🗓️: Oct 6, Sunday at 7 PM ET. Don’t miss this expert session on the molecular drivers “Born to be Bad”! 🎙️ Host: Dr. Qiong Zhang @Qiong511 #HemePath
Jing Di (邸菁) MD, PhD retweeted
We are hosting our 2nd virtual open house for prospective applicants to learn more about our pathology residency and our department @UK_HealthCare
We are excited to meet you you all!
Please sign up using forms.office.com/r/q3B5YwCzQ…
@MatchToPath @Path_SIG #Match2025 #PathMatch25
Curious about how AI is transforming hematopathology? Here is an insightful webinar to learn more! 👇🏻
Jing Di (邸菁) MD, PhD retweeted
China outdoes itself again…
After setting a world record with over 8,000 drones in a light show…
Now they have a 10,000 drone light show.
Jing Di (邸菁) MD, PhD retweeted
🌟 Excited to learn more about Pediatric Renal Tumors? Join us for a special CAPA webinar this Saturday (9/28, 7 pm ET) featuring Dr. Bonnie Balzer from Cedars-Sinai. We will discuss the subtypes and differential diagnoses of pediatric renal tumors. Host: Dr. Huihui Ye #GUpath
